Ulf Grawunder
Director/Board Member at WUXI XDC CAYMAN INC.
Ulf Grawunder active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WUXI XDC CAYMAN INC. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| ADAGENE INC. | Director/Board Member | 01/04/2024 | - |
| Independent Dir/Board Member | 01/04/2024 | - | |
NBE-Therapeutics AG
 NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Director/Board Member | 18/04/2012 | - |
| Chief Operating Officer | 03/08/2020 | - | |
| Founder | 18/04/2012 | - | |
| Chief Executive Officer | 18/04/2012 | 03/08/2020 | |
| T-CURX GmbH | Chief Executive Officer | 01/09/2022 | - |
| Founder | 01/09/2022 | - | |
Viopas Venture Consulting GmbH
 Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Corporate Officer/Principal | 01/01/2022 | - |
Career history of Ulf Grawunder
Former positions of Ulf Grawunder
| Companies | Position | Start | End |
|---|---|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | - | - |
4-Antibody AG
 4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Chief Tech/Sci/R&D Officer | 12/12/2002 | - |
| Founder | 17/07/2009 | - |
Training of Ulf Grawunder
| University of Basel | Doctorate Degree |
| University of Bayreuth | Graduate Degree |
Statistics
International
| Switzerland | 5 |
| Germany | 3 |
| China | 3 |
Operational
| Founder | 3 |
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ADAGENE INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Private companies | 4 |
|---|---|
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology 4-Antibody AG was discovers and develops drugs. The company was founded in 2002 and headquartered in Basel, Switzerland. | Health Technology |
NBE-Therapeutics AG
NBE-Therapeutics AG BiotechnologyHealth Technology NBE-Therapeutics AG operates as biotechnology company. It develops next-generation ADCs improving treatment options for cancer patients. The company was founded by Ulf Grawunder in 2012 and is based in Basel, Swizerland. | Health Technology |
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Finance |
| T-CURX GmbH |
- Stock Market
- Insiders
- Ulf Grawunder
- Experience
